Staff

Main navigation

2023 Bernice Grafstein Lecture in Neuroscience presents Dr. Marina Picciotto

Published: 16 October 2023

The Integrated Program in Neuroscience (IPN) invites Dr. Marina Picciotto is give the 2023 Bernice Grafstein Lecture in Neuroscience. Dr. Picciotto is the Charles B. G. Murphy Professor of...

Read more about 2023 Bernice Grafstein Lecture in Neuroscience presents Dr. Marina Picciotto

Achievements of clinicians and scientists recognized with King Charles III Coronation Medals

Published: 14 March 2025

Five clinicians and scientists at The Neuro have been awarded King Charles III Coronation Medals in recognition of their contributions to our understanding of neurological disease. The Coronation...

Read more about Achievements of clinicians and scientists recognized with King Charles III Coronation Medals

Project to create AI model for ALS receives Génome Québec funding

Published: 17 March 2025

$400,000 will fuel public-private collaboration to discover new disease biomarkers...

Read more about Project to create AI model for ALS receives Génome Québec funding

Genetic sequencing project receives more than $8 million in funding

Published: 18 March 2025

NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians...

Read more about Genetic sequencing project receives more than $8 million in funding

Six principal investigators from The Neuro receive CIHR grants

Published: 10 February 2025

Projects include important research on Parkinson’s, glioblastoma and dementia

Read more about Six principal investigators from The Neuro receive CIHR grants

Alan Evans receives Order of Canada

Published: 30 June 2025

Career of breakthroughs in neuroimaging recognized with one of the nation’s highest honours ...

Read more about Alan Evans receives Order of Canada

Latest Alzheimer’s drug shown less effective in females than males

Published: 18 March 2025

Since becoming only the second Alzheimer’s-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD...